Search

everythinglearnresearchcommunity

for

Search:↓

Injecting platelet-rich plasma is a safe and effective way to treat hair loss.

A patient with a severe type of hair loss experienced partial hair regrowth after treatment with a specific light therapy and a medication called interferon α2a.

A man's skin cancer improved and some of his hair grew back after treatment with a special light therapy and a medication.

The patient with total hair loss did not regrow hair despite treatment, indicating a poor outlook for this type of hair loss.

Scalp reduction can improve hair distribution in certain baldness cases but requires careful patient selection and understanding of facial structure.

58% of men aged 30-50 have hair loss, with severity increasing with age.

Androgens contribute to common male hair loss; more research needed for hair growth medication.

Advanced male pattern baldness affects the back of the scalp, reducing hair follicles.

Personalized Ayurvedic treatment can effectively regrow hair in androgenetic alopecia.

A boy with severe Vitamin D-resistant rickets did not respond to treatment and lacked a common symptom, suggesting a need for alternative treatments.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

5α reductase type 2 enzyme mutation and oxidative stress may increase androgenetic alopecia risk in Egyptians.

At least 87% of Indian men experience hair loss, with type II being most common and severity increasing with age.

Early onset hair loss linked to genetics and androgen levels.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

Male pattern baldness, especially the vertex type, could be an early sign of cardiovascular risk factors like high cholesterol and diabetes.

Baldness is more common in Chinese men than women, increasing with age, and is influenced by genetics.

AGA increased yearly, type I most common, and family history and seborrheic dermatitis often linked.

Chinese men have lower AGA rates than Caucasians, with type III vertex most common; family history is important.

Genes linked to fibrosis are more active in people with central centrifugal cicatricial alopecia.

Botox increased hair count in men with baldness and might work by improving scalp blood flow.

Botulinum toxin treatment improves hair follicle width and length in androgenetic alopecia.

Finasteride, a drug used for certain conditions, can cause serious side effects like sexual dysfunction, suicidal thoughts, and increased diabetes risk, and there's a need for more awareness and research about these effects.

Title change to "Central Centrifugal Cicatricial Alopecia (CCCA)"; common in African American women; hair-grooming methods may contribute; no effective therapy found; trials needed.

Botulinum Toxin Type A can increase hair density and improve hair thickness in androgenetic alopecia with minimal side effects.

Mechanical stress contributes to hair loss in androgenetic alopecia.

Small injections of dutasteride improved hair thickness in men with hair loss without major side effects.

Higher sebum levels are linked to more severe male baldness.

Cyclosporin doesn't stop hair loss.

Severe hair loss (androgenetic alopecia) is linked to higher risk of heart disease (cardiovascular atherosclerosis).